{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:53:06Z","timestamp":1788821586176,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["cstc2021jcyj-msxmX0036"],"award-info":[{"award-number":["cstc2021jcyj-msxmX0036"]}],"id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project of Second Affiliated Hospital of Chongqing Medical University","award":["kryc-yq-2216"],"award-info":[{"award-number":["kryc-yq-2216"]}]},{"DOI":"10.13039\/501100017676","name":"Chunhui Project Foundation of the Education Department of China","doi-asserted-by":"publisher","award":["HZKY20220218"],"award-info":[{"award-number":["HZKY20220218"]}],"id":[{"id":"10.13039\/501100017676","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04079-7","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:56:06Z","timestamp":1739958966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Leukemia and risk of stroke: a Mendelian randomization analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaoyao","family":"Yi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingrui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"key":"4079_CR1","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, et al. The 2016 revision to the world health organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391\u2013405.","journal-title":"Blood"},{"key":"4079_CR2","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IB, de Berti O. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: lymphoid neoplasms. Leukemia. 2022;36:1720\u201348.","journal-title":"Leukemia"},{"key":"4079_CR3","doi-asserted-by":"publisher","first-page":"e1139","DOI":"10.1002\/cnr2.1139","volume":"2","author":"T Nemkov","year":"2019","unstructured":"Nemkov T, D\u2019Alessandro A, Reisz JA. Metabolic underpinnings of leukemia pathology and treatment. Cancer Rep Hoboken NJ. 2019;2:e1139.","journal-title":"Cancer Rep Hoboken NJ"},{"key":"4079_CR4","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1053\/j.seminoncol.2006.03.004","volume":"33","author":"J Glass","year":"2006","unstructured":"Glass J. Neurologic complications of lymphoma and leukemia. Semin Oncol. 2006;33:342\u20137.","journal-title":"Semin Oncol"},{"key":"4079_CR5","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S0140-6736(16)30506-2","volume":"388","author":"MJ O\u2019Donnell","year":"2016","unstructured":"O\u2019Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet Lond Engl. 2016;388:761\u201375.","journal-title":"Lancet Lond Engl"},{"key":"4079_CR6","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa1804492","volume":"379","author":"VL Feigin","year":"2018","unstructured":"GBD 2016 Lifetime Risk of Stroke Collaborators, Feigin VL, Nguyen G, Cercy K, Johnson CO, Alam T, et al. Global, Regional, and Country-Specific Lifetime risks of Stroke, 1990 and 2016. N Engl J Med. 2018;379:2429\u201337.","journal-title":"N Engl J Med"},{"key":"4079_CR7","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.clml.2017.09.008","volume":"18","author":"C Del Prete","year":"2018","unstructured":"Del Prete C, Kim T, Lansigan F, Shatzel J, Friedman H. The Epidemiology and Clinical associations of Stroke in patients with Acute myeloid leukemia: a review of 10,972 admissions from the 2012 National Inpatient Sample. Clin Lymphoma Myeloma Leuk. 2018;18:74\u2013e771.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4079_CR8","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.wneu.2020.06.091","volume":"144","author":"A Raghavan","year":"2020","unstructured":"Raghavan A, Wright CH, Wright JM, Jensen K, Malloy P, Elder T, et al. Outcomes and clinical characteristics of intracranial hemorrhage in patients with hematologic malignancies: a systematic literature review. World Neurosurg. 2020;144:e15\u201324.","journal-title":"World Neurosurg"},{"key":"4079_CR9","doi-asserted-by":"publisher","first-page":"3480","DOI":"10.1007\/s00415-021-10441-9","volume":"268","author":"JM Ferro","year":"2021","unstructured":"Ferro JM, Infante J. Cerebrovascular manifestations in hematological diseases: an update. J Neurol. 2021;268:3480\u201392.","journal-title":"J Neurol"},{"key":"4079_CR10","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1111\/j.1365-2141.2010.08524.x","volume":"152","author":"RF Grace","year":"2011","unstructured":"Grace RF, Dahlberg SE, Neuberg D, Sallan SE, Connors JM, Neufeld EJ, et al. The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols. Br J Haematol. 2011;152:452\u20139.","journal-title":"Br J Haematol"},{"key":"4079_CR11","doi-asserted-by":"publisher","first-page":"e183788","DOI":"10.1001\/jamanetworkopen.2018.3788","volume":"1","author":"H Riaz","year":"2018","unstructured":"Riaz H, Khan MS, Siddiqi TJ, Usman MS, Shah N, Goyal A, et al. Association between obesity and cardiovascular outcomes: a systematic review and meta-analysis of mendelian randomization studies. JAMA Netw Open. 2018;1:e183788.","journal-title":"JAMA Netw Open"},{"key":"4079_CR12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/STROKEAHA.120.031710","volume":"52","author":"EL Harshfield","year":"2021","unstructured":"Harshfield EL, Georgakis MK, Malik R, Dichgans M, Markus HS. Modifiable lifestyle factors and risk of stroke: a mendelian randomization analysis. Stroke. 2021;52:931\u20136.","journal-title":"Stroke"},{"key":"4079_CR13","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1161\/STROKEAHA.120.029902","volume":"51","author":"OE Titova","year":"2020","unstructured":"Titova OE, Micha\u00eblsson K, Larsson SC. Sleep duration and stroke: prospective cohort study and mendelian randomization analysis. Stroke. 2020;51:3279\u201385.","journal-title":"Stroke"},{"key":"4079_CR14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s40471-017-0128-6","volume":"4","author":"J Zheng","year":"2017","unstructured":"Zheng J, Baird D, Borges M-C, Bowden J, Hemani G, Haycock P, et al. Recent developments in mendelian randomization studies. Curr Epidemiol Rep. 2017;4:330\u201345.","journal-title":"Curr Epidemiol Rep"},{"key":"4079_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.5853\/jos.2021.01340","volume":"24","author":"H-Q Li","year":"2022","unstructured":"Li H-Q, Feng Y-W, Yang Y-X, Leng X-Y, Zhang PC, Chen S-D, et al. Causal relations between exposome and stroke: a mendelian randomization study. J Stroke. 2022;24:236\u201344.","journal-title":"J Stroke"},{"key":"4079_CR16","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613:508\u201318.","journal-title":"Nature"},{"key":"4079_CR17","doi-asserted-by":"crossref","unstructured":"Z LJ. Z, H F, J Y. A generalized linear mixed model association tool for biobank-scale data. Nat Genet. 2021;53.","DOI":"10.1038\/s41588-021-00954-4"},{"key":"4079_CR18","doi-asserted-by":"publisher","first-page":"3898","DOI":"10.1080\/10408398.2020.1870927","volume":"62","author":"T Zotta","year":"2022","unstructured":"Zotta T, Ricciardi A, Condelli N, Parente E. Metataxonomic and metagenomic approaches for the study of undefined strain starters for cheese manufacture. Crit Rev Food Sci Nutr. 2022;62:3898\u2013912.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"4079_CR19","first-page":"1875","volume":"48","author":"B Z\u00f6ller","year":"2012","unstructured":"Z\u00f6ller B, Ji J, Sundquist J, Sundquist K. Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer Oxf Engl 1990. 2012;48:1875\u201383.","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"4079_CR20","doi-asserted-by":"publisher","first-page":"106818","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106818","volume":"31","author":"FO Otite","year":"2022","unstructured":"Otite FO, Somani S, Aneni E, Akano E, Patel SD, Anikpezie N, et al. Trends in age and sex-specific prevalence of cancer and cancer subtypes in acute ischemic stroke from 2007\u20132019. J Stroke Cerebrovasc Dis off J Natl Stroke Assoc. 2022;31:106818.","journal-title":"J Stroke Cerebrovasc Dis off J Natl Stroke Assoc"},{"key":"4079_CR21","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1093\/annonc\/mdn755","volume":"20","author":"C-Y Chen","year":"2009","unstructured":"Chen C-Y, Tai C-H, Tsay W, Chen P-Y, Tien H-F. Prediction of fatal intracranial hemorrhage in patients with acute myeloid leukemia. Ann Oncol off J Eur Soc Med Oncol. 2009;20:1100\u20134.","journal-title":"Ann Oncol off J Eur Soc Med Oncol"},{"key":"4079_CR22","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.clml.2021.08.006","volume":"22","author":"M Ammad Ud Din","year":"2022","unstructured":"Ammad Ud Din M, Thakkar S, Patel H, Saeed H, Hussain SA, Liaqat H, et al. The impact of Atrial Fibrillation on hospitalization outcomes for patients with chronic lymphocytic leukemia using the National Inpatient Sample Database. Clin Lymphoma Myeloma Leuk. 2022;22:98\u2013104.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4079_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11060-017-2741-0","volume":"137","author":"S Quintas","year":"2018","unstructured":"Quintas S, Rogado J, Gull\u00f3n P, Pacheco-Barcia V, Dotor Garc\u00eda-Soto J, Reig-Rosell\u00f3 G, et al. Predictors of unknown cancer in patients with ischemic stroke. J Neurooncol. 2018;137:551\u20137.","journal-title":"J Neurooncol"},{"key":"4079_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jns.2011.02.004","volume":"304","author":"O Fagniez","year":"2011","unstructured":"Fagniez O, Tertian G, Dreyfus M, Ducreux D, Adams D, Denier C. Hematological disorders related cerebral infarctions are mostly multifocal. J Neurol Sci. 2011;304:87\u201392.","journal-title":"J Neurol Sci"},{"key":"4079_CR25","doi-asserted-by":"publisher","first-page":"3890","DOI":"10.1182\/blood-2011-12-379008","volume":"119","author":"G Juliusson","year":"2012","unstructured":"Juliusson G, Lazarevic V, H\u00f6rstedt A-S, Hagberg O, H\u00f6glund M, Swedish Acute Leukemia Registry Group. Acute myeloid leukemia in the real world: why population-based registries are needed. Blood. 2012;119:3890\u20139.","journal-title":"Blood"},{"key":"4079_CR26","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1210\/en.2018-00465","volume":"159","author":"M Roy-O\u2019Reilly","year":"2018","unstructured":"Roy-O\u2019Reilly M, McCullough LD. Age and sex are critical factors in Ischemic Stroke Pathology. Endocrinology. 2018;159:3120\u201331.","journal-title":"Endocrinology"},{"key":"4079_CR27","doi-asserted-by":"crossref","unstructured":"Tj K, Fk S, Cj W, Cm C, Wg GP. W, Chronic lymphocytic leukaemia. Nat Rev Dis Primer. 2017;3.","DOI":"10.1038\/nrdp.2016.99"},{"key":"4079_CR28","doi-asserted-by":"crossref","unstructured":"Zy PK, Xf C, Dd H, Rj Z. G, M H. Inflammation and atherosclerosis: signaling pathways and therapeutic intervention. Signal Transduct Target Ther. 2022;7.","DOI":"10.1038\/s41392-022-00955-7"},{"key":"4079_CR29","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41571-019-0239-8","volume":"16","author":"F Bosch","year":"2019","unstructured":"Bosch F, Dalla-Favera R. Chronic lymphocytic leukaemia: from genetics to treatment. Nat Rev Clin Oncol. 2019;16:684\u2013701.","journal-title":"Nat Rev Clin Oncol"},{"key":"4079_CR30","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.3390\/cancers16183196","volume":"16","author":"J K\u0119pski","year":"2024","unstructured":"K\u0119pski J, Szmit S, Lech-Mara\u0144da E. Time relationship between the occurrence of a thromboembolic event and the diagnosis of hematological malignancies. Cancers. 2024;16:3196.","journal-title":"Cancers"},{"key":"4079_CR31","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1634\/theoncologist.2013-0226","volume":"18","author":"GH Lyman","year":"2013","unstructured":"Lyman GH, Eckert L, Wang Y, Wang H, Cohen A. Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis. Oncologist. 2013;18:1321\u20139.","journal-title":"Oncologist"},{"key":"4079_CR32","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.thromres.2009.12.023","volume":"125","author":"AA Khorana","year":"2010","unstructured":"Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res. 2010;125:490\u20133.","journal-title":"Thromb Res"},{"key":"4079_CR33","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/S0140-6736(24)00595-6","volume":"404","author":"N Jain","year":"2024","unstructured":"Jain N, Wierda WG, O\u2019Brien S. Chronic lymphocytic leukaemia. Lancet Lond Engl. 2024;404:694\u2013706.","journal-title":"Lancet Lond Engl"},{"key":"4079_CR34","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1182\/blood-2016-05-712828","volume":"128","author":"DP Leong","year":"2016","unstructured":"Leong DP, Caron F, Hillis C, Duan A, Healey JS, Fraser G, et al. The risk of atrial fibrillation with ibrutinib use: a systematic review and meta-analysis. Blood. 2016;128:138\u201340.","journal-title":"Blood"},{"key":"4079_CR35","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/bjh.14321","volume":"175","author":"SP Mulligan","year":"2016","unstructured":"Mulligan SP, Ward CM, Whalley D, Hilmer SN. Atrial fibrillation, anticoagulant stroke prophylaxis and bleeding risk with ibrutinib therapy for chronic lymphocytic leukaemia and lymphoproliferative disorders. Br J Haematol. 2016;175:359\u201364.","journal-title":"Br J Haematol"},{"key":"4079_CR36","doi-asserted-by":"publisher","first-page":"e959","DOI":"10.1016\/j.clml.2022.07.004","volume":"22","author":"A Narezkina","year":"2022","unstructured":"Narezkina A, Akhter N, Lu X, Emond B, Panjabi S, Forbes SP, et al. Real-world persistence and time to next treatment with ibrutinib in patients with chronic lymphocytic leukemia\/small lymphocytic lymphoma including patients at high risk for atrial fibrillation or stroke. Clin Lymphoma Myeloma Leuk. 2022;22:e959\u201371.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4079_CR37","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1111\/ajco.13179","volume":"15","author":"S Ezad","year":"2019","unstructured":"Ezad S, Khan AA, Cheema H, Ashraf A, Ngo DTM, Sverdlov AL, et al. Ibrutinib-related atrial fibrillation: a single center Australian experience. Asia Pac J Clin Oncol. 2019;15:e187\u201390.","journal-title":"Asia Pac J Clin Oncol"},{"key":"4079_CR38","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.jemermed.2009.04.061","volume":"42","author":"AE Mu\u00f1iz","year":"2012","unstructured":"Mu\u00f1iz AE. Myocardial infarction and stroke as the presenting symptoms of acute myeloid leukemia. J Emerg Med. 2012;42:651\u20134.","journal-title":"J Emerg Med"},{"key":"4079_CR39","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1212\/01.WNL.0000129912.56486.2B","volume":"62","author":"DM Cestari","year":"2004","unstructured":"Cestari DM, Weine DM, Panageas KS, Segal AZ, DeAngelis LM. Stroke in patients with cancer: incidence and etiology. Neurology. 2004;62:2025\u201330.","journal-title":"Neurology"},{"key":"4079_CR40","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/s-0030-1255224","volume":"30","author":"LR Rogers","year":"2010","unstructured":"Rogers LR. Cerebrovascular complications in patients with Cancer. Semin Neurol. 2010;30:311\u20139.","journal-title":"Semin Neurol"},{"key":"4079_CR41","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1200\/JCO.21.00693","volume":"39","author":"H Abdel-Qadir","year":"2021","unstructured":"Abdel-Qadir H, Sabrie N, Leong D, Pang A, Austin PC, Prica A, et al. Cardiovascular Risk Associated with Ibrutinib Use in Chronic lymphocytic leukemia: a Population-based Cohort Study. J Clin Oncol off J Am Soc Clin Oncol. 2021;39:3453\u201362.","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"4079_CR42","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.041","volume":"24","author":"SM Zuurbier","year":"2015","unstructured":"Zuurbier SM, Lauw MN, Coutinho JM, Majoie CBLM, Holt B, van der, Cornelissen JJ, et al. Clinical course of cerebral venous thrombosis in adult Acute Lymphoblastic Leukemia. J Stroke Cerebrovasc Dis. 2015;24:1679\u201384.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"4079_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/ana.26129","volume":"90","author":"BB Navi","year":"2021","unstructured":"Navi BB, Sherman CP, Genova R, Mathias R, Lansdale KN, LeMoss NM, et al. Mechanisms of ischemic stroke in patients with Cancer: a prospective study. Ann Neurol. 2021;90:159\u201369.","journal-title":"Ann Neurol"},{"key":"4079_CR44","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1111\/jth.15779","volume":"20","author":"BB Navi","year":"2022","unstructured":"Navi BB, Zhang C, Sherman CP, Genova R, LeMoss NM, Kamel H, et al. Ischemic stroke with cancer: hematologic and embolic biomarkers and clinical outcomes. J Thromb Haemost JTH. 2022;20:2046\u201357.","journal-title":"J Thromb Haemost JTH"},{"key":"4079_CR45","doi-asserted-by":"publisher","first-page":"15769","DOI":"10.3390\/ijms232415769","volume":"23","author":"M-Y Sun","year":"2022","unstructured":"Sun M-Y, Bhaskar SMM. When two maladies Meet: Disease Burden and Pathophysiology of Stroke in Cancer. Int J Mol Sci. 2022;23:15769.","journal-title":"Int J Mol Sci"},{"key":"4079_CR46","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1182\/blood-2006-04-015511","volume":"108","author":"V Caruso","year":"2006","unstructured":"Caruso V, Iacoviello L, Di Castelnuovo A, Storti S, Mariani G, de Gaetano G, et al. Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients. Blood. 2006;108:2216\u201322.","journal-title":"Blood"},{"key":"4079_CR47","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/bjh.16695","volume":"191","author":"H Sibai","year":"2020","unstructured":"Sibai H, Chen R, Liu X, Falcone U, Schimmer A, Schuh A, et al. Anticoagulation prophylaxis reduces venous thromboembolism rate in adult acute lymphoblastic leukaemia treated with asparaginase-based therapy. Br J Haematol. 2020;191:748\u201354.","journal-title":"Br J Haematol"},{"key":"4079_CR48","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12944-020-01257-z","volume":"19","author":"Z Zhuang","year":"2020","unstructured":"Zhuang Z, Gao M, Yang R, Li N, Liu Z, Cao W, et al. Association of physical activity, sedentary behaviours and sleep duration with cardiovascular diseases and lipid profiles: a mendelian randomization analysis. Lipids Health Dis. 2020;19:86.","journal-title":"Lipids Health Dis"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04079-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04079-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04079-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:56:13Z","timestamp":1739958973000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04079-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4079"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04079-7","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"3 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"68"}}